Ligand Pharmaceuticals Incorporated Insider Transactions
Ligand Pharmaceuticals Incorporated Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
LAMATTINA JOHN L
Director |
Sell | 2,406 @ $123.65 | $297,502 | 29,515 | 11/27/2024 | 12/02/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248,228 | 58,068 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720,379 | 50,978 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20,513 | 50,777 | 09/23/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 2,000 @ $99.60 | $199,201 | 22,534 | 09/23/2024 | 09/25/2024 | |
Espinoza Octavio
CFO |
Sell | 200 @ $103.98 | $20,796 | 25,685 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 275 @ $103.86 | $28,562 | 25,410 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 800 @ $103.95 | $83,160 | 24,610 | 09/20/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,275 @ $104.10 | $653,238 | 50,777 | 09/20/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 1,500 @ $106.39 | $159,591 | 22,534 | 08/28/2024 | 08/30/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,177 @ $105.02 | $648,684 | 54,722 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 5,212 @ $106.32 | $554,147 | 49,510 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,037 @ $104.09 | $212,040 | 65,174 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 4,275 @ $105.13 | $449,439 | 60,899 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 1,157 @ $105.54 | $122,110 | 67,211 | 08/22/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 18,245 @ $98.50 | $1.80 M | 68,368 | 08/09/2024 | 08/13/2024 | |
Davis Todd C
CEO |
Buy | 2,500 @ $97.39 | $243,481 | 123,010 | 08/08/2024 | 08/09/2024 | |
Espinoza Octavio
CFO |
Sell | 134 @ $86.65 | $11,611 | 23,379 | 05/17/2024 | 05/17/2024 | |
Espinoza Octavio
CFO |
Sell | 5,022 @ $86.67 | $435,233 | 23,513 | 05/17/2024 | 05/17/2024 | |
Espinoza Octavio
CFO |
Sell | 2,264 @ $86.00 | $194,712 | 21,618 | 05/16/2024 | 05/17/2024 |
Ligand Pharmaceuticals Incorporated FAQ's
The list of insiders at Ligand Pharmaceuticals Incorporated includes Espinoza Octavio, Sabba Stephen L, Gray Nancy Ryan, Reardon Andrew, Korenberg Matthew E, Davis Todd C, LAMATTINA JOHN L.
Insiders have sold a total of 104,189 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 9.92 M sold.
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Espinoza Octavio ($1.29 M), Sabba Stephen L ($140,650), Gray Nancy Ryan ($77,713), Reardon Andrew ($1.19 M), Korenberg Matthew E ($6.92 M), LAMATTINA JOHN L ($297,502),
Insiders have purchased a total of 2,500 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 243,481 sold.
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($243,481),